Cargando…

Prevalence of Aspergillus-Derived Mycotoxins (Ochratoxin, Aflatoxin, and Gliotoxin) and Their Distribution in the Urinalysis of ME/CFS Patients

Myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) is a known complex, multi-organ system disorder with a sudden or subacute onset. ME/CFS occurs most commonly among women between 30 and 50 years of age. The current diagnostic criteria of ME/CFS, as defined by the Centers for Disease Contro...

Descripción completa

Detalles Bibliográficos
Autores principales: Wu, Ting Yu, Khorramshahi, Taura, Taylor, Lindsey A., Bansal, Nikita S., Rodriguez, Betsy, Rey, Irma R.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8872248/
https://www.ncbi.nlm.nih.gov/pubmed/35206241
http://dx.doi.org/10.3390/ijerph19042052
_version_ 1784657193237217280
author Wu, Ting Yu
Khorramshahi, Taura
Taylor, Lindsey A.
Bansal, Nikita S.
Rodriguez, Betsy
Rey, Irma R.
author_facet Wu, Ting Yu
Khorramshahi, Taura
Taylor, Lindsey A.
Bansal, Nikita S.
Rodriguez, Betsy
Rey, Irma R.
author_sort Wu, Ting Yu
collection PubMed
description Myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) is a known complex, multi-organ system disorder with a sudden or subacute onset. ME/CFS occurs most commonly among women between 30 and 50 years of age. The current diagnostic criteria of ME/CFS, as defined by the Centers for Disease Control and Prevention, includes: profound fatigue and post-exertional malaise (>6 mo) unrelieved by rest, persistent cognitive impairment or orthostatic intolerance, and chronic unrefreshing sleep. Despite reported associations between ME/CFS onset and exposure to infectious agents (viral, bacterial, or fungal), the pathophysiology of ME/CFS remains unknown. In this prevalence study, we investigated the rates of Aspergillus-derived toxin levels, Aflatoxin (AF), Ochratoxin A (OTA), and Gliotoxin (GT), in the urinalysis of 236 ME/CFS patients with a history of chronic exposure to mold (i.e., from water-damaged buildings). Among ME/CFS patients reporting chronic exposure to mold, we found evidence of exposure in 92.4 percent of patients, with OTA being the most prevalent mycotoxin. Mold distributions (OTA, AF, and GT) in the urinalysis all demonstrated right skewness, while the distribution of age of ME/CFS patients diagnosed showed no deviation from normality. This study aims to provide preliminary, epidemiological evidence among ME/CFS patients who were diagnosed in South Florida with a history of exposure to mycotoxins. Based on these findings, we proposed how future control studies should approach investigating the association between chronic mold exposure and the diagnosis of ME/CFS.
format Online
Article
Text
id pubmed-8872248
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-88722482022-02-25 Prevalence of Aspergillus-Derived Mycotoxins (Ochratoxin, Aflatoxin, and Gliotoxin) and Their Distribution in the Urinalysis of ME/CFS Patients Wu, Ting Yu Khorramshahi, Taura Taylor, Lindsey A. Bansal, Nikita S. Rodriguez, Betsy Rey, Irma R. Int J Environ Res Public Health Article Myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) is a known complex, multi-organ system disorder with a sudden or subacute onset. ME/CFS occurs most commonly among women between 30 and 50 years of age. The current diagnostic criteria of ME/CFS, as defined by the Centers for Disease Control and Prevention, includes: profound fatigue and post-exertional malaise (>6 mo) unrelieved by rest, persistent cognitive impairment or orthostatic intolerance, and chronic unrefreshing sleep. Despite reported associations between ME/CFS onset and exposure to infectious agents (viral, bacterial, or fungal), the pathophysiology of ME/CFS remains unknown. In this prevalence study, we investigated the rates of Aspergillus-derived toxin levels, Aflatoxin (AF), Ochratoxin A (OTA), and Gliotoxin (GT), in the urinalysis of 236 ME/CFS patients with a history of chronic exposure to mold (i.e., from water-damaged buildings). Among ME/CFS patients reporting chronic exposure to mold, we found evidence of exposure in 92.4 percent of patients, with OTA being the most prevalent mycotoxin. Mold distributions (OTA, AF, and GT) in the urinalysis all demonstrated right skewness, while the distribution of age of ME/CFS patients diagnosed showed no deviation from normality. This study aims to provide preliminary, epidemiological evidence among ME/CFS patients who were diagnosed in South Florida with a history of exposure to mycotoxins. Based on these findings, we proposed how future control studies should approach investigating the association between chronic mold exposure and the diagnosis of ME/CFS. MDPI 2022-02-12 /pmc/articles/PMC8872248/ /pubmed/35206241 http://dx.doi.org/10.3390/ijerph19042052 Text en © 2022 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Wu, Ting Yu
Khorramshahi, Taura
Taylor, Lindsey A.
Bansal, Nikita S.
Rodriguez, Betsy
Rey, Irma R.
Prevalence of Aspergillus-Derived Mycotoxins (Ochratoxin, Aflatoxin, and Gliotoxin) and Their Distribution in the Urinalysis of ME/CFS Patients
title Prevalence of Aspergillus-Derived Mycotoxins (Ochratoxin, Aflatoxin, and Gliotoxin) and Their Distribution in the Urinalysis of ME/CFS Patients
title_full Prevalence of Aspergillus-Derived Mycotoxins (Ochratoxin, Aflatoxin, and Gliotoxin) and Their Distribution in the Urinalysis of ME/CFS Patients
title_fullStr Prevalence of Aspergillus-Derived Mycotoxins (Ochratoxin, Aflatoxin, and Gliotoxin) and Their Distribution in the Urinalysis of ME/CFS Patients
title_full_unstemmed Prevalence of Aspergillus-Derived Mycotoxins (Ochratoxin, Aflatoxin, and Gliotoxin) and Their Distribution in the Urinalysis of ME/CFS Patients
title_short Prevalence of Aspergillus-Derived Mycotoxins (Ochratoxin, Aflatoxin, and Gliotoxin) and Their Distribution in the Urinalysis of ME/CFS Patients
title_sort prevalence of aspergillus-derived mycotoxins (ochratoxin, aflatoxin, and gliotoxin) and their distribution in the urinalysis of me/cfs patients
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8872248/
https://www.ncbi.nlm.nih.gov/pubmed/35206241
http://dx.doi.org/10.3390/ijerph19042052
work_keys_str_mv AT wutingyu prevalenceofaspergillusderivedmycotoxinsochratoxinaflatoxinandgliotoxinandtheirdistributionintheurinalysisofmecfspatients
AT khorramshahitaura prevalenceofaspergillusderivedmycotoxinsochratoxinaflatoxinandgliotoxinandtheirdistributionintheurinalysisofmecfspatients
AT taylorlindseya prevalenceofaspergillusderivedmycotoxinsochratoxinaflatoxinandgliotoxinandtheirdistributionintheurinalysisofmecfspatients
AT bansalnikitas prevalenceofaspergillusderivedmycotoxinsochratoxinaflatoxinandgliotoxinandtheirdistributionintheurinalysisofmecfspatients
AT rodriguezbetsy prevalenceofaspergillusderivedmycotoxinsochratoxinaflatoxinandgliotoxinandtheirdistributionintheurinalysisofmecfspatients
AT reyirmar prevalenceofaspergillusderivedmycotoxinsochratoxinaflatoxinandgliotoxinandtheirdistributionintheurinalysisofmecfspatients